AU2001284188A1 - Thiazolidine derivatives and its use as antifungal agent - Google Patents

Thiazolidine derivatives and its use as antifungal agent

Info

Publication number
AU2001284188A1
AU2001284188A1 AU2001284188A AU8418801A AU2001284188A1 AU 2001284188 A1 AU2001284188 A1 AU 2001284188A1 AU 2001284188 A AU2001284188 A AU 2001284188A AU 8418801 A AU8418801 A AU 8418801A AU 2001284188 A1 AU2001284188 A1 AU 2001284188A1
Authority
AU
Australia
Prior art keywords
antifungal agent
thiazolidine derivatives
nr3r4
thiazolidine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001284188A
Other languages
English (en)
Inventor
Judi Charlotte Neuss
Michael Glen Orchard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford Glycosciences UK Ltd
Original Assignee
Oxford Glycosciences UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford Glycosciences UK Ltd filed Critical Oxford Glycosciences UK Ltd
Publication of AU2001284188A1 publication Critical patent/AU2001284188A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
AU2001284188A 2000-08-31 2001-08-30 Thiazolidine derivatives and its use as antifungal agent Abandoned AU2001284188A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0021419 2000-08-31
GBGB0021419.7A GB0021419D0 (en) 2000-08-31 2000-08-31 Compounds
PCT/GB2001/003860 WO2002022612A1 (en) 2000-08-31 2001-08-30 Thiazolidine derivatives and its use as antifungal agent

Publications (1)

Publication Number Publication Date
AU2001284188A1 true AU2001284188A1 (en) 2002-03-26

Family

ID=9898614

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001284188A Abandoned AU2001284188A1 (en) 2000-08-31 2001-08-30 Thiazolidine derivatives and its use as antifungal agent

Country Status (9)

Country Link
US (1) US6740670B2 (https=)
EP (1) EP1313731B1 (https=)
JP (1) JP2004509121A (https=)
AT (1) ATE482954T1 (https=)
AU (1) AU2001284188A1 (https=)
DE (1) DE60143165D1 (https=)
ES (1) ES2353685T3 (https=)
GB (1) GB0021419D0 (https=)
WO (1) WO2002022612A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS53252B (sr) 2003-08-11 2014-08-29 F.Hoffmann-La Roche Ag. Piperazin sa or-supstituisanom fenil grupom i njihova upotreba kao inhibitora glyt1
AU2005224091B2 (en) 2004-03-15 2012-02-02 Janssen Pharmaceutica, N.V. Novel compounds as opioid receptor modulators
PL1828154T3 (pl) 2004-12-09 2009-10-30 Hoffmann La Roche Pochodne fenylopiperazynometanonu
ATE457989T1 (de) 2004-12-15 2010-03-15 Hoffmann La Roche Bi- und trizyklische substituierte phenyl- methanone als inhibitoren von glycin-i (glyt-1)- transportern zur behandlung der alzheimer- krankheit
US7485637B2 (en) 2005-01-04 2009-02-03 Hoffmann-La Roche Inc. Benzoyl-tetrahydropiperidine derivatives
BRPI0519794A2 (pt) 2005-01-07 2009-03-17 Hoffmann La Roche derivados de [4-(heteroaril)piperazin-1-il]-(fenil 2,5-substituìdo)metanona como inibidores de transportador de glicina 1 (glyt-1) para o tratamento de distúrbios neurológicos e neuropsiquiátricos
ATE435650T1 (de) 2005-01-18 2009-07-15 Hoffmann La Roche 2,5-disubstituierte phenylmethanonderivative als glycintransporter-1-inhibitoren (glyt-1) zur behandlung von neurologischen und neuropsychiatrischen störungen
ATE447572T1 (de) 2005-01-26 2009-11-15 Hoffmann La Roche Phenylmethanonderivate und ihre verwendung als glycin-transporter-1-hemmer
DE602006010665D1 (en) 2005-02-07 2010-01-07 Hoffmann La Roche Heterocyclsche substituierte phenylmethanone als inhibitoren des glycintransporters 1
WO2009143041A1 (en) 2008-05-20 2009-11-26 Merck & Co., Inc. Efficient production of heterologous proteins using mannosyl transferase inhibitors
US8957066B2 (en) 2011-02-28 2015-02-17 Biomarin Pharmaceutical Inc. Histone deacetylase inhibitors
US10059723B2 (en) 2011-02-28 2018-08-28 Biomarin Pharmaceutical Inc. Histone deacetylase inhibitors
RU2662153C1 (ru) * 2017-04-20 2018-07-24 Общество С Ограниченной Ответственностью "Дермавитал Групп" Гибридные эфиры на основе производных тиазолидин-2,4-диона и азолов (1н-1,3-имидазола и 1н-1,3,4-триазола) и их применение
RU2690161C1 (ru) * 2018-06-28 2019-05-31 Общество С Ограниченной Ответственностью "Дермавитал Групп" 3,5-Замещенные производные тиазолидин-2,4-диона, обладающие противомикробной активностью
RU2703997C1 (ru) * 2018-12-13 2019-10-23 Общество с ограниченной ответственностью "Л-Био" Гибридные амиды на основе триазола и тиазолидина, обладающие антимикробной активностью
US11292776B2 (en) 2019-12-12 2022-04-05 University Of Sharjah Small molecule inhibitors of fungal hyphae and biofilm formation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US47109A (en) * 1865-04-04 Improvement in governors
FR1604530A (https=) * 1967-06-06 1971-11-29
JPS5740478A (en) * 1980-08-22 1982-03-06 Ono Pharmaceut Co Ltd Rhodanine derivative, its preparation and aldose reductase inhibitor containing rhodanine derivative
DE4318550A1 (de) * 1993-06-04 1994-12-08 Boehringer Mannheim Gmbh Aryliden-4-oxo-2-thioxo-3- thiazolidincarbonsäuren, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE19835316A1 (de) * 1998-08-05 2000-02-10 Bosch Gmbh Robert Gesteuerte Gleichrichterbrücke mit Überspannungsschutz
US6673816B1 (en) * 1998-09-30 2004-01-06 Angelika Esswein Rhodanine carboxylic acid derivatives for the treatment and prevention of metabolic bone disorders

Also Published As

Publication number Publication date
DE60143165D1 (de) 2010-11-11
EP1313731B1 (en) 2010-09-29
EP1313731A1 (en) 2003-05-28
US20030216453A1 (en) 2003-11-20
WO2002022612A8 (en) 2002-05-23
ATE482954T1 (de) 2010-10-15
ES2353685T3 (es) 2011-03-04
US6740670B2 (en) 2004-05-25
WO2002022612A1 (en) 2002-03-21
GB0021419D0 (en) 2000-10-18
JP2004509121A (ja) 2004-03-25

Similar Documents

Publication Publication Date Title
AU2001284188A1 (en) Thiazolidine derivatives and its use as antifungal agent
BR0208365A (pt) Derivados de 2-amino-propanol
AU2001284190A1 (en) Benzylidene thiazolidinediones and their use as antimycotic agents
DK0423714T3 (da) Hårrevitaliseringsmiddel
DK109487A (da) Fungicid paa basis af et cyanopyrrolderivat
AU8243291A (en) Hydrogenated rapamycin derivatives
NZ533861A (en) Proline compounds as NS3-serine protease inhibitors for use in treatment of hepatitis C virus infection
AU6055894A (en) Benzofuranyl- and -thiophenyl-alkanecarboxyclic acid derivatives
DK1078923T3 (da) Fremgangsmåde til fremstilling af benzothiophenderivater
WO2004063330A3 (en) (2-carboxamido) (3-amino) thiophene compounds
WO2002032871A3 (en) Compounds and methods for treating multidrug resistance
PT96664A (pt) Processo para a preparacao de derivados neuroprotectores de 3-piperidino-4-hidroxicromano
AU8062487A (en) New substituted cephalosporin sulfones as anti-inflammatory and antidegenerative agents
GR3033350T3 (en) Use of Beta-aminopropionic acid derivatives as fungicides
CA2121123A1 (en) Anti-seborrhoeic formulation
SE0004101D0 (sv) New use
ES2118575T3 (es) 2-heteroaril-5,11-dihidro-6h-dipirido(3,2-b:2',3'-e)(1,4)diazepinas y su uso en la prevencion o tratamiento de la infeccion con hiv.
EP0831869A4 (en) DIPHOSPHONATE DERIVATIVES OF THERAPEUTIC AGENTS
ATE250610T1 (de) Kaliumkanal-blockierende mittel
DE3665584D1 (de) Spiro-imidazolidines as aldose reductase inhibitors
BR0009453B1 (pt) processo para a preparação de um composto.
ATE286887T1 (de) Antibakterielle mittel
EP1207166A3 (en) Process for the preparation of 6.alpha.-fluoro,9,11.beta.-epoxy-steroids
CA2421008A1 (en) Substituted heterocyclic compounds for treating multidrug resistance
AU8678682A (en) Aminoglycoside derivatives